Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01463280 · ClinicalTrials.gov registry record · Phase 1
Effect of Tumescent Lidocaine on Platelet Function
A Phase 1 study, sponsored by Klein, Jeffrey A., M.D..
- Completed
- Registry status
- Phase 1
- Development phase
- 129
- Enrollment target
NCT01463280 is a Phase 1 study that has completed, run by Klein, Jeffrey A., M.D.. The registered enrollment target is 129 participants.
The verdict
NCT01463280, a Phase 1 study, has completed, sponsored by Klein, Jeffrey A., M.D..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 129 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of lidocaine, delivered into subcutaneous tissue for tumescent local anesthesia, on platelet activation following the tumescent liposuction.
Interventions
- DRUG tumescent lidocaine infiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01463280
The ClinicalTrials.gov registry entry for NCT01463280 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Klein, Jeffrey A., M.D., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tumescent lidocaine infiltration is the first listed.
NCT01463280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01463280 about?
NCT01463280 is a clinical study titled "Effect of Tumescent Lidocaine on Platelet Function". The purpose of this study is to evaluate the effect of lidocaine, delivered into subcutaneous tissue for tumescent local anesthesia, on platelet activation following the tumescent liposuction.
What is the current status of trial NCT01463280?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 129 participants. The study started on 2011-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01463280?
The interventions under investigation include: tumescent lidocaine infiltration (DRUG).
Who is sponsoring clinical trial NCT01463280?
This trial is sponsored by Klein, Jeffrey A., M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.